logo.png
GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE
June 10, 2024 10:50 ET | GlucoTrack, Inc.
Rutherford, NJ, June 10, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and...
logo.png
GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
June 05, 2024 08:30 ET | GlucoTrack, Inc.
Highly accurate continuous blood glucose monitor demonstrates Mean Absolute Relative Difference (MARD) of 4.7% at Day 90 Continuous blood glucose monitor offers the potential for simplified, discreet...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
May 14, 2024 16:00 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces First Quarter 2024 Results
May 13, 2024 09:15 ET | Sanara MedTech Inc.
FORT WORTH, TX, May 13, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
May 10, 2024 14:43 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates
April 29, 2024 09:15 ET | Sanara MedTech Inc.
FORT WORTH, TX, April 29, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
April 10, 2024 09:00 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
April 09, 2024 09:05 ET | NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE,...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
April 04, 2024 09:00 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
March 26, 2024 09:00 ET | NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control Limited...